How Private Company Shares Are Priced

Public company shareholders check their net worth every trading day. A glance at their brokerage account shows the exact price per share, multiplied by their position, giving them a number. Private company shareholders have no such clarity. There is no ticker. There is no exchange. There is no daily price.

This raises an obvious question: how do private shares get priced at all? The answer is that there are multiple methods, each with different levels of accuracy and relevance. Understanding which method is being used - and why it matters - is essential to knowing what your shares are actually worth.

The Core Problem: No Market, No Price

The fundamental challenge is simple: private shares don't trade on any public exchange. There is no continuous bid-ask spread. There is no market-clearing price set by supply and demand. Valuations of private companies are set by individual deals - one founder talking to one investor, or one shareholder negotiating with one buyer. Each transaction is unique, with its own terms, timing, and circumstances.

This lack of a public market creates information asymmetry. When you sell a private share, the buyer typically knows more about the company's future than you do. They may have access to management, board materials, and customer intelligence. You may be relying on last year's revenue and the company's public statements. Both of you are trying to price something in an illiquid, opaque market.

Method 1: The Last Funding Round (409A)

The simplest method is also the most commonly cited, but also the most misleading. When someone says "the company just raised a Series D at $8 billion valuation," they usually mean that professional investors paid a specific price per share for preferred stock. That price becomes the baseline for valuing all other shares.

For employees with stock options, the IRS requires companies to set a "fair market value" for option grants using an independent 409A valuation. This valuation uses the last funding round as a starting point, then applies discounts to reach a lower number for common stock. The logic: preferred shareholders got a better deal because they had leverage and information, so common shares are worth less.

But here's the critical limitation: the last round price is not your price. It's the price paid by professional investors buying preferred shares with protective provisions, board seats, and anti-dilution rights. Your common shares have none of these. And if the company has raised money since then, the cap stack has changed entirely - more shares have been issued, diluting your ownership percentage.

Method 2: Comparable Public Company Multiples

Another approach looks at similar public companies and applies their trading multiples to the private company's financials. For a SaaS company, this might mean taking comparable public SaaS companies trading at 8x revenue, then applying that 8x multiple to the private company's ARR (annual recurring revenue) to estimate its valuation.

For example: if Earlyasset had $10 million in ARR and SaaS comparables trade at 8x revenue, the comps method would value Earlyasset at $80 million. Divide that by total shares outstanding, and you get a price per share.

This method is more sophisticated than simply taking the last round price. It forces you to make explicit assumptions about growth, unit economics, and market risk. The problem is the assumptions themselves. Is the private company actually comparable to those public companies? Do they have the same growth rate, margins, and customer concentration? Almost never exactly.

Earlyasset uses comps as one input in its pricing model, but it doesn't rely on it alone. Comps can move dramatically based on public market sentiment, which may or may not reflect the private company's true trajectory.

Method 3: Recent Secondary Market Transactions

What did a buyer actually pay for shares in this company - or a similar company - recently? This is perhaps the most honest price signal available. Secondary market transactions are real money, real shareholders, real buyers with real conviction about what the shares are worth.

The challenge is access to data. Secondary transactions are private. They don't get published on a stock exchange. You might hear through your company network that someone sold shares at a certain price, but that data is anecdotal and potentially unreliable. What was the share class? What were the deal terms? Did the seller have other reasons to accept a lower price?

Earlyasset aggregates data from secondary transactions across its platform and the broader market to build real pricing signals by company and share class. This method works because it's based on actual transaction prices - not projections, not multiples applied to estimates, but real dollars exchanged.

Method 4: Algorithmic Pricing Models

The most comprehensive approach combines all the above methods with additional financial and market data to build a dynamic price estimate. Earlyasset's pricing model blends recent funding rounds, comparable company multiples, secondary market transaction data, company growth rates, and macro conditions to produce a price estimate.

The advantage: you're not relying on any single method. The disadvantage: the model is only as good as its inputs and assumptions.

Pricing models also account for something the other methods often ignore: your specific share class and position in the cap stack. Your common shares are worth something different than series A preferred, which is worth something different than series D preferred. Earlyasset prices each share class separately because they have different liquidation preferences, participation rights, and timing to liquidity.

Why Share Class and Cap Stack Matter

Here's something most shareholders miss: the pricing method matters less than understanding your position in the capital structure. Two shareholders in the same company with the same percentage ownership can have vastly different equity values depending on what class of shares they hold.

If you hold common stock and the company has 3 series of preferred with liquidation preferences totaling $200 million, and the company exits at $300 million, the preferred gets paid $200 million first, leaving $100 million for common shareholders. Your percentage ownership of the exit is very different from your percentage ownership of the company valuation.

Earlyasset prices common, Series A preferred, Series B preferred, and so on - separately - because they are economically different securities. This is one reason why the method of pricing matters so much. If someone is pricing the "whole company" at $500 million and dividing it equally across all share classes, they're doing it wrong.

Indicative Price vs. Transaction Price

One final distinction that often goes unmentioned: there's a difference between an indicative price (what Earlyasset or your company tells you your shares might be worth) and a transaction price (what someone actually offers you for those shares in a real deal).

An indicative price is useful for planning, for understanding your net worth, and for making decisions about exercise or sale. A transaction price is the actual number that matters when you're making a deal. Between these two, there's usually a spread - a discount that reflects the specific buyer, the specific deal terms, timing, and your personal situation.

Understanding this distinction keeps you grounded. Your Earlyasset price estimate is valuable context for your financial planning. It is not a guarantee of what you'll receive if you sell. But it's a much better starting point than trying to do the math yourself based on company valuation and percentage ownership.

Getting to a real transaction price requires understanding the four methods above - but more importantly, it requires understanding what you own and why it matters. Earlyasset brings all of this together: accurate valuation method, share-class-specific pricing, and a framework for understanding what the number actually means for you. That clarity is the first step toward making informed decisions about your private equity.

Price estimates are provided for informational purposes only and do not constitute financial, investment, or legal advice. Estimates are based on proprietary models and available market data and may not reflect actual transaction prices.